BY: FRED ROTTNEK, MD, MAHCM
Long before there was Catholic health care, members of the church cared for each other, sometimes as individuals and sometimes as members of religious orders. Caring for others' health was part of community and parish life — special facilities and buildings were rare, and care was provided in homes, in churches and even on the streets. In fact, the modern version of a hospital didn't exist until the 18th century. Prior to this, most activities in buildings set aside for the care of the sick offered chiefly palliative care. The focus of work was comfort, not investigation. And the care was provided by religious orders.
BY: PATRICK RIOUX, MA
Addiction issues have been a focal point of faith-based health care for many years. There has been a shift, however, from abuse of illegal drugs like cocaine and heroin to issues related to prescription drug addiction, especially opioids.
CHI St. Gabriel's Health, a multifacility rural health organization located in Little Falls, Minnesota, has developed a systematic and effective approach to treating opioid abuse resulting in state, regional and national accolades including the American Hospital Association's NOVA Award and the Minnesota Hospital Association's Innovation of the Year Award, among others.
INTERVIEW WITH LUCINDA L. MAINE, PhD, RPh
First, tell us a little bit about your background and the American Association of Colleges of Pharmacy — and its role in the pharmacy profession.
I assumed my position as executive vice president and CEO of AACP in July 2002. Prior to that time, I had been in senior leadership for the American Pharmacists Association (APhA) for 10 years and had also served in academic positions at the University of Minnesota and at Samford University [in Birmingham, Alabama]. It was the perfect melding of my professional experience — half in academia and half in association management.
BY: KEVIN FITZGERALD, SJ, PhD, PhD
It is a time of great challenge and opportunity in the world of drug discovery and development. Enormous challenges exist because of issues such as the rapid expansion of anti-microbial resistance (see article on page 61), the relative ease of making and distributing poor quality or counterfeit drugs and the devastating increase in the misuse of drugs such as opioids. To address these challenges, drug developers and manufacturers will have a range of research options that also is increasing rapidly. It includes access to medical information and biological samples from across the globe, as well as recent breakthroughs in ways to manipulate an individual's genome and physiology.